Natera, Inc. (NTRA) income statement
NASDAQ · Healthcare · Medical - Diagnostics & Research · 6,138 employees · CEO Steven Leonard Chapman
- Price
- $414.30 -4.98%
- Market cap
- $59.7B
- Enterprise value
- $58.9B
- Last report
- Q2 '26 filed 2026-08-07
- Next report
- 2026-11-05 EPS est. -$0.28
Natera, Inc. (NTRA) reported revenue of $753M for Q2 '26 (+37.7% year on year), operating income of -$75.8M (-10.1% of revenue) and net income of -$67M. Over the last four quarters revenue was $2.71B.
Income statement
| Income statement | Trend | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $268M | $311M | $368M | $413M | $440M | $476M | $502M | $547M | $592M | $666M | $697M | $753M | |
| Cost of revenue | $147M | $151M | $159M | $170M | $168M | $176M | $185M | $200M | $208M | $219M | $245M | $268M | |
| Gross profit | $121M | $160M | $209M | $243M | $272M | $300M | $317M | $347M | $384M | $447M | $451M | $485M | |
| Research & development | $77.2M | $83M | $88.6M | $89.1M | $96.9M | $129M | $129M | $146M | $173M | $175M | $211M | $228M | |
| Other operating expenses | $0 | $0 | $0 | $0 | $0 | $0 | $452K | $465K | $0 | $3.11M | $6.32M | $5.71M | |
| Operating expenses | $232M | $244M | $283M | $287M | $311M | $364M | $396M | $457M | $482M | $470M | $545M | $561M | |
| Operating income | -$111M | -$84.5M | -$74.3M | -$43.9M | -$39.3M | -$64.7M | -$79.2M | -$110M | -$97.6M | -$22.8M | -$93.5M | -$75.8M | |
| Interest income | $5.41M | $9.84M | $10.3M | $10.5M | $11.6M | $10.9M | $13.4M | $10.7M | $11.3M | $24.2M | $9.6M | $9.45M | |
| Interest expense | $3.25M | $3.15M | $3.12M | $3.13M | $3.14M | $1.29M | $1.01M | $1.03M | $1.05M | $7.15M | $892K | $890K | |
| Other non-operating income (gains on investments, FX ...) | -$5.41M | -$9.84M | -$10.3M | -$10.5M | -$11.6M | -$10.9M | -$13.4M | -$10.7M | -$11.3M | -$16.6M | -$7.82M | -$9.45M | |
| Total non-operating income | $2.15M | $6.7M | $7.14M | $7.33M | $8.48M | $9.61M | $12.4M | $9.71M | $10.2M | $9.46M | $8.71M | $8.56M | |
| Income before tax | -$109M | -$77.8M | -$67.2M | -$36.6M | -$30.9M | -$55.1M | -$66.8M | -$101M | -$87.3M | -$13.3M | -$84.8M | -$67.2M | |
| Income tax | $202K | $191K | $428K | $892K | $730K | -$1.36M | $173K | $275K | $207K | -$60.6M | $283K | -$261K | |
| Net income | -$109M | -$78M | -$67.6M | -$37.5M | -$31.6M | -$53.8M | -$66.9M | -$101M | -$87.5M | $47.3M | -$85.1M | -$67M | |
| EPS (basic) | -$0.95 | -$0.65 | -$0.56 | -$0.30 | -$0.26 | -$0.41 | -$0.50 | -$0.74 | -$0.64 | $0.35 | -$0.60 | -$0.47 | |
| EPS (diluted) | -$0.95 | -$0.65 | -$0.56 | -$0.30 | -$0.26 | -$0.41 | -$0.50 | -$0.74 | -$0.64 | $0.35 | -$0.60 | -$0.47 | |
| Shares (basic, weighted) | 115M | 119M | 121M | 123M | 124M | 125M | 135M | 136M | 137M | 137M | 142M | 143M | |
| Shares (diluted, weighted) | 115M | 119M | 121M | 123M | 124M | 125M | 135M | 136M | 137M | 137M | 142M | 143M | |
| Depreciation & amortization | $6.99M | $6.91M | $7.06M | $7.92M | $8.2M | $7.79M | $9.24M | $9.86M | $10.3M | $14.1M | $20.2M | $21.2M | |
| EBITDA | -$98.6M | -$67.8M | -$57M | -$25.5M | -$19.5M | -$46M | -$56.5M | -$89.8M | -$76M | $7.92M | -$65.5M | -$45.2M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $217M | $211M | $258M | $302M | $391M | $625M | $820M | $1.08B | $1.7B | $2.31B | |
| Cost of revenue | $136M | $140M | $166M | $175M | $204M | $318M | $456M | $590M | $674M | $811M | |
| Gross profit | $81.5M | $71.3M | $91.6M | $127M | $187M | $307M | $364M | $493M | $1.02B | $1.5B | |
| Research & development | $41.9M | $50.1M | $51.4M | $51.4M | $100M | $264M | $316M | $321M | $404M | $624M | |
| General & administrative | $136M | $155M | $155M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other operating expenses | $0 | $0 | $0 | -$14.4M | $0 | $0 | $0 | $0 | $0 | $4.03M | |
| Operating expenses | $178M | $205M | $206M | $243M | $404M | $775M | $905M | $939M | $1.25B | $1.81B | |
| Operating income | -$96.5M | -$134M | -$115M | -$116M | -$216M | -$468M | -$541M | -$446M | -$222M | -$310M | |
| Interest income | $1.4M | $2.38M | $0 | $4.15M | $7.56M | $5.38M | $3.54M | $24.4M | $43.2M | $45.9M | |
| Interest expense | $533K | $4.21M | $10.5M | $10.7M | $15.1M | $8.31M | $9.32M | $12.6M | $10.7M | $4.07M | |
| Other non-operating income (gains on investments, FX ...) | $3.16M | -$2.38M | $0 | -$4.15M | -$1.71M | -$5.38M | -$3.54M | -$24.4M | -$43.2M | -$45.9M | |
| Total non-operating income | $865K | -$1.83M | -$13.2M | -$6.54M | -$13.4M | -$2.92M | -$5.78M | $11.7M | $32.6M | $41.8M | |
| Income before tax | -$95.6M | -$136M | -$128M | -$123M | -$230M | -$471M | -$547M | -$435M | -$190M | -$268M | |
| Income tax | $142K | $454K | $321K | $2M | $98K | $618K | $978K | $271K | $695K | -$59.9M | |
| Net income | -$95.8M | -$136M | -$128M | -$125M | -$230M | -$472M | -$548M | -$435M | -$190M | -$208M | |
| EPS (basic) | -$1.86 | -$2.56 | -$2.22 | -$1.79 | -$2.84 | -$5.21 | -$5.57 | -$3.78 | -$1.53 | -$1.52 | |
| EPS (diluted) | -$1.86 | -$2.54 | -$2.22 | -$1.79 | -$2.84 | -$5.21 | -$5.57 | -$3.78 | -$1.53 | -$1.52 | |
| Shares (basic, weighted) | 51.4M | 53.3M | 57.7M | 69.6M | 81M | 90.6M | 98.4M | 115M | 125M | 137M | |
| Shares (diluted, weighted) | 51.6M | 53.6M | 57.8M | 69.6M | 81M | 90.6M | 98.4M | 115M | 125M | 137M | |
| Depreciation & amortization | $6.18M | $7.14M | $7.5M | $7.73M | $8.61M | $11.3M | $16.7M | $24.1M | $31M | $43.5M | |
| EBITDA | -$93.4M | -$126M | -$107M | -$104M | -$206M | -$452M | -$521M | -$398M | -$148M | -$221M |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-02